Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus

D. P. Bick, D. McCorkle, W. S. Stanley, H. J. Stern, P. Staszak, Gary Berkovitz, C. M. Meyers, R. I. Kelley

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

A cytogenetically normal male fetus was subsequently found to have female external genitalia, a cardiac malformation and mid-trimester intra-uterine growth retardation by ultrasound examination. The maternal serum oestriol level was low. The combination of low oestriol and sonographic findings suggested Smith-Lemli-Opitz syndrome (SLO), which was confirmed by a markedly increased amniotic fluid level of 7-dehydrocholesterol. We review the differential diagnosis of apparent sex reversal in a fetus and low maternal serum oestriol level. To further examine the specificity of low maternal oestriol level as a marker for SLO a follow-up study of 12141 pregnancies screened for Down syndrome using three biochemical markers: alpha-fetoprotein, beta-human chorionic gonadotrophin and oestriol was performed. 26 pregnancies had an oestriol level that was 0.25 MoM or less. SLO was not diagnosed clinically in any of the liveborn children ascertained through a low maternal oestriol level. Nine of the pregnancies ended in spontaneous miscarriage. Although the frequency of SLO in pregnancies with low maternal oestriol levels or sex-reversed fetuses is unknown, the diagnosis of SLO should, nevertheless, be considered in both clinical settings.

Original languageEnglish
Pages (from-to)68-71
Number of pages4
JournalPrenatal Diagnosis
Volume19
Issue number1
DOIs
StatePublished - Feb 4 1999

Fingerprint

Smith-Lemli-Opitz Syndrome
Estriol
Prenatal Diagnosis
Fetus
Mothers
Pregnancy
Serum
Female Genitalia
alpha-Fetoproteins
Spontaneous Abortion
Chorionic Gonadotropin
Amniotic Fluid
Down Syndrome
Differential Diagnosis
Biomarkers

Keywords

  • Maternal serum screening
  • Oestriol
  • Prenatal diagnosis
  • Sex reversal
  • Smith-Lemli-Opitz syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Obstetrics and Gynecology

Cite this

Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus. / Bick, D. P.; McCorkle, D.; Stanley, W. S.; Stern, H. J.; Staszak, P.; Berkovitz, Gary; Meyers, C. M.; Kelley, R. I.

In: Prenatal Diagnosis, Vol. 19, No. 1, 04.02.1999, p. 68-71.

Research output: Contribution to journalArticle

Bick, D. P. ; McCorkle, D. ; Stanley, W. S. ; Stern, H. J. ; Staszak, P. ; Berkovitz, Gary ; Meyers, C. M. ; Kelley, R. I. / Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus. In: Prenatal Diagnosis. 1999 ; Vol. 19, No. 1. pp. 68-71.
@article{0f419465042648a3b48508961010f96d,
title = "Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus",
abstract = "A cytogenetically normal male fetus was subsequently found to have female external genitalia, a cardiac malformation and mid-trimester intra-uterine growth retardation by ultrasound examination. The maternal serum oestriol level was low. The combination of low oestriol and sonographic findings suggested Smith-Lemli-Opitz syndrome (SLO), which was confirmed by a markedly increased amniotic fluid level of 7-dehydrocholesterol. We review the differential diagnosis of apparent sex reversal in a fetus and low maternal serum oestriol level. To further examine the specificity of low maternal oestriol level as a marker for SLO a follow-up study of 12141 pregnancies screened for Down syndrome using three biochemical markers: alpha-fetoprotein, beta-human chorionic gonadotrophin and oestriol was performed. 26 pregnancies had an oestriol level that was 0.25 MoM or less. SLO was not diagnosed clinically in any of the liveborn children ascertained through a low maternal oestriol level. Nine of the pregnancies ended in spontaneous miscarriage. Although the frequency of SLO in pregnancies with low maternal oestriol levels or sex-reversed fetuses is unknown, the diagnosis of SLO should, nevertheless, be considered in both clinical settings.",
keywords = "Maternal serum screening, Oestriol, Prenatal diagnosis, Sex reversal, Smith-Lemli-Opitz syndrome",
author = "Bick, {D. P.} and D. McCorkle and Stanley, {W. S.} and Stern, {H. J.} and P. Staszak and Gary Berkovitz and Meyers, {C. M.} and Kelley, {R. I.}",
year = "1999",
month = "2",
day = "4",
doi = "10.1002/(SICI)1097-0223(199901)19:1<68::AID-PD461>3.0.CO;2-3",
language = "English",
volume = "19",
pages = "68--71",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Prenatal diagnosis of Smith-Lemli-Opitz syndrome in a pregnancy with low maternal serum oestriol and a sex-reversed fetus

AU - Bick, D. P.

AU - McCorkle, D.

AU - Stanley, W. S.

AU - Stern, H. J.

AU - Staszak, P.

AU - Berkovitz, Gary

AU - Meyers, C. M.

AU - Kelley, R. I.

PY - 1999/2/4

Y1 - 1999/2/4

N2 - A cytogenetically normal male fetus was subsequently found to have female external genitalia, a cardiac malformation and mid-trimester intra-uterine growth retardation by ultrasound examination. The maternal serum oestriol level was low. The combination of low oestriol and sonographic findings suggested Smith-Lemli-Opitz syndrome (SLO), which was confirmed by a markedly increased amniotic fluid level of 7-dehydrocholesterol. We review the differential diagnosis of apparent sex reversal in a fetus and low maternal serum oestriol level. To further examine the specificity of low maternal oestriol level as a marker for SLO a follow-up study of 12141 pregnancies screened for Down syndrome using three biochemical markers: alpha-fetoprotein, beta-human chorionic gonadotrophin and oestriol was performed. 26 pregnancies had an oestriol level that was 0.25 MoM or less. SLO was not diagnosed clinically in any of the liveborn children ascertained through a low maternal oestriol level. Nine of the pregnancies ended in spontaneous miscarriage. Although the frequency of SLO in pregnancies with low maternal oestriol levels or sex-reversed fetuses is unknown, the diagnosis of SLO should, nevertheless, be considered in both clinical settings.

AB - A cytogenetically normal male fetus was subsequently found to have female external genitalia, a cardiac malformation and mid-trimester intra-uterine growth retardation by ultrasound examination. The maternal serum oestriol level was low. The combination of low oestriol and sonographic findings suggested Smith-Lemli-Opitz syndrome (SLO), which was confirmed by a markedly increased amniotic fluid level of 7-dehydrocholesterol. We review the differential diagnosis of apparent sex reversal in a fetus and low maternal serum oestriol level. To further examine the specificity of low maternal oestriol level as a marker for SLO a follow-up study of 12141 pregnancies screened for Down syndrome using three biochemical markers: alpha-fetoprotein, beta-human chorionic gonadotrophin and oestriol was performed. 26 pregnancies had an oestriol level that was 0.25 MoM or less. SLO was not diagnosed clinically in any of the liveborn children ascertained through a low maternal oestriol level. Nine of the pregnancies ended in spontaneous miscarriage. Although the frequency of SLO in pregnancies with low maternal oestriol levels or sex-reversed fetuses is unknown, the diagnosis of SLO should, nevertheless, be considered in both clinical settings.

KW - Maternal serum screening

KW - Oestriol

KW - Prenatal diagnosis

KW - Sex reversal

KW - Smith-Lemli-Opitz syndrome

UR - http://www.scopus.com/inward/record.url?scp=0032925365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032925365&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1097-0223(199901)19:1<68::AID-PD461>3.0.CO;2-3

DO - 10.1002/(SICI)1097-0223(199901)19:1<68::AID-PD461>3.0.CO;2-3

M3 - Article

VL - 19

SP - 68

EP - 71

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 1

ER -